16 April 2024

Introducing William Faria, the New Vice President of Biometrics at Avance Clinical

Introducing William Faria, the New Vice President of Biometrics at Avance Clinical

Avance Clinical, the Australian and North American market-leading Contract Research Organization (CRO) for biotechs, proudly welcomes William Faria as its new Vice President of Biometrics. With an extensive background in data management within the biometrics sector, William brings a wealth of experience and a global perspective to his new role.

William’s journey in the clinical research industry commenced in 2002 in the bustling hub of Boston, where he worked with distinguished organizations including Parexel, Wyeth, Biogen-Idec, and Boston Scientific. His dedication to advancing healthcare also led him to collaborate with the Harvard Clinical Research Institute. In 2007, driven by a passion for humanitarian causes, William embarked on a transformative journey with Doctors Without Borders, rendering healthcare support in Haiti, Nigeria, South Sudan, and Ethiopia. This enriching experience prompted his relocation to Europe, where he assumed leadership roles at Keyrus Biopharma in Paris and Galderma in the south of France.

A graduate of The Johns Hopkins University, where he studied Behavioral Biology, William’s academic foundation further enhances his multidisciplinary approach to biometrics. In his previous role, William contributed significantly to the early phase group of Syneos Health, focusing on biometrics optimization across various functional areas.

What drew William to Avance Clinical was its forward-thinking leadership and remarkable growth trajectory. Currently based in Gap, France, William is poised to spearhead the biometrics division, steering the team through a period of expansion, and implementing cutting-edge technologies to enhance efficiency and quality.

“I am thrilled to join Avance Clinical, where innovation thrives in a dynamic environment,” William expresses. “My key focus will be on guiding the team through this period of growth and leveraging emerging technologies to drive excellence.”

The most intriguing aspect of Avance Clinical for William lies in its potential for innovation within a rapidly growing organization. As the new Vice President of Biometrics, William is poised to lead Avance Clinical towards new horizons, fostering a culture of excellence and innovation in biotech drug development.

Please join us in extending a warm welcome to William Faria as he embarks on this exciting journey with Avance Clinical. Together, we look forward to advancing healthcare solutions and making meaningful contributions to the biotech industry, to support areas of unmet need.

About Avance Clinical

Avance Clinical is the largest premium full-service Australian and North American CRO delivering quality clinical trials, with globally accepted data, in Australia, New Zealand and the US for international biotechs. The company’s clients are biotechs completing Phase I to Phase III of their drug development program that requires fast, agile, and adaptive solution-oriented clinical research services.

Frost & Sullivan Awards

Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past four years, has been providing CRO services in the region for more than 26 years.

Pre-clinical through to mid to late phase

Avance Clinical offers pre-clinical services with their experienced ClinicReady team right from pre-clinical through to Phase III clinical services leveraging significant Australian Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

With experience across more than 120 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.


Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, TrialHub, Certinia, Salesforce, Zelta and Medrio are just some of the technology partners.

Related Articles